A study led by researchers of the Institute of Biomedicine of the University of Barcelona (IBUB) has developed a new pharmacological tool capable of simultaneously administering three oligonucleotide-based drugs, each acting against a different therapeutic target within the cell.
Read Also
- Disney and Universal Announce Theme Park Closures Ahead of Hurricane Milton
- Big Deal Days Samsung Galaxy Watch deals
- Roblox is overinflating its user numbers, according to eye-popping report
- New seed fossil sheds light on wind dispersal in plants
- Save $20 on this meat thermometer that gives temp readings in one second or less
- Amazon Prime Day deal: Save 15% on SPOT satellite messengers and trackers
- The best Prime Day Samsung Galaxy deals include up to 25 percent off the Galaxy S24 lineup
- Tesla Robotaxi reveal: What to expect
- NASA laser-based data transmission demonstrates serviceable internet 290 million miles from Earth
- Free Uber Rides Available to Floridians Evacuating to Hurricane Milton Shelters
Latest phys
- New seed fossil sheds light on wind dispersal in plants
- Why using a brand nickname in marketing is not a good idea
- Report spotlights urgent issues faced by Mobile Indigenous populations
- Experimental archaeology sheds light on skill and technique in Bronze Age spear combat
- Team presents new theoretical strategy for generating asymmetric distributions in probability and statistics
- How a witch-hunting manual and social networks helped ignite Europe's witch craze
- Comprehensive efforts needed to develop health-promoting learning environments, review finds
- Social media users opt for new privacy haven, study finds
- US finalizes rule to remove lead pipes within a decade
- Research team develops metallodrug-antibiotic combination strategy to combat superbugs